China Biologic Products, Inc. (CBPO)

[surf1944]

China Biologic Products (CBPO) fell 7% after the Guizhou Provincial Health Department issued the revised "Plan for Guizhou Provincial Blood Collection Institutional Setting (2011-14).” The revised plan reduces the number of counties that are permitted to set up plasma collection stations from the originally proposed 10 counties to four counties. The revised plan, in the relevant part, states that

in accordance with the demographic distribution, economic development condition, disease prevalence, and actual situation of plasma supply for the manufacturing of blood-based products, plasma collection stations will be set up in four counties, including Kai Yang, Du Shan, Pu Ding, Huang Ping, etc.

Based on the company's preliminary understanding of the revised plan, subject to further clarifications from Guizhou Provincial government regarding the implementation of the plan, the company currently anticipates the licenses of its four other plasma collection stations in Dan Zhai, Wei Ning, San Sui, and Na Yong counties may not be renewed (until at least 2014) after their respective plasma collection permits expire at the end of July.

http://seekingalpha.com/article/279926-5-stocks-lower-on-friday?source=yahoo